Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCZ | Q05513 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 3/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24762270 | 1.00 | PRKCZ (0.35) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL24762913 | 0.97 | SMN1; SMN2 (0.34) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL23944559 | 0.96 | KDM4E (0.40) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL23944820 | 0.96 | CYP11B1 (0.38) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL23944537 | 0.95 | KDM4E (0.39) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL24762187 | 0.95 | KDM4E (0.41) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL23944358 | 0.95 | PRKCZ (0.38) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL24762323 | 0.94 | KDM4E (0.39) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL23944378 | 0.94 | PRKCZ (0.38) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 | |
| SCHEMBL24763440 | 0.93 | PRKCZ (0.35) | PRKCZMEN1KMT2ASMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220402928-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2022-12-22 | — | — | US | disclosed |
| WO-2021210910-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | 주식회사 엘지화학 | 2021-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402928-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CCNL2, CRY1, CRY2 | PRKCZ 4773/4885MEN1 1025/4885KMT2A 3186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.